Michael Aaron Brodney

This inventor holds 65 USPTO granted patents and 21 published patent applications, plus 10 CIPO patents and 21 EPO patents, primarily in Dopamine D1 Ligands (CPC class C07D). Top assignees: Pfizer Corporation, Vertex Pharmaceuticals, Inc.. Active years: 2007-2026.

USPTO Granted Patents = 65 (Patent Applications = 21)

% Patents Active = 60.0

CIPO Patents = 10 (Patent Applications = 27)

EPO Patents = 21 (Patent Applications = 36)

Average Co-Inventor Count = 6.2

ph-index = 12

Forward Citations = 365(Granted Patents)

Forward Citations (Not Self Cited) = 109(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Old Lyme, CT (US) (2008)
East Lyme, CT (US) (2007 - 2011)
Newtons, MA (US) (2016)
Newton, MA (US) (2014 - 2024)

Company Filing History:

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Dopamine D1 Ligands

APOL1 Inhibitors

Alpha-1-Antitrypsin Modulators

Pyrano Derivatives

Heteroaromatic Compounds

MAGL Inhibitors

Imidazoquinoline Derivatives

Piperazine Derivatives

Heterocyclic Compounds

Thiazolyl Amides

Naphthyridines

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662471 - 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2026-06-23),

2. 12612379 - Inhibitors of APOL1 and methods of using same (2026-04-28),

3. 12502376 - Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2025-12-23),

4. 12421249 - Inhibitors of APOL1 and methods of using same (2025-09-23),

5. 12398119 - Piperazine azaspiro derivatives (2025-08-26),

6. 12331057 - Modulators of alpha-1 antitrypsin (2025-06-17),

7. 12060346 - Inhibitors of APOL1 and methods of using same (2024-08-13),

8. 11964961 - Heteroaromatic compounds and their use as dopamine D1 ligands (2024-04-23),

9. 11905284 - 5,7-dihydro-pyrrolo-pyridine derivatives (2024-02-20),

10. 11884672 - Modulators of alpha-1 antitrypsin (2024-01-30),

11. 11866446 - Inhibitors of APOL1 and methods of using same (2024-01-09),

12. 11623924 - Modulators of alpha-1 antitrypsin (2023-04-11),

13. 11618746 - Inhibitors of APOL1 and methods of using same (2023-04-04),

14. 11524954 - Piperazine azaspiro derivatives (2022-12-13),

15. 11312713 - Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors (2022-04-26),

Title: The Innovative Mind of Michael Aaron Brodney

Introduction: Michael Aaron Brodney is a renowned inventor based in Newton, Massachusetts. His creative mind and passion for innovation have led to numerous groundbreaking inventions in various fields.

Latest Patents: Michael Aaron Brodney holds several patents in the areas of technology, healthcare, and consumer products. His latest patents include a cutting-edge medical device for remote patient monitoring and a revolutionary smart home system for energy efficiency.

Career Highlights: Throughout his career, Michael Aaron Brodney has been recognized for his exceptional problem-solving skills and ability to think outside the box. He has worked with top companies to develop innovative solutions that have had a significant impact on the industry.

Collaborations: Michael Aaron Brodney has collaborated with leading researchers, engineers, and designers to bring his inventions to life. His collaborative approach has resulted in successful products that have improved the lives of many.

Conclusion: In conclusion, Michael Aaron Brodney is a visionary inventor who continues to push the boundaries of innovation. His dedication to creating cutting-edge solutions underscores his commitment to making the world a better place through technology.